Trajectories of depressive symptoms before diagnosis of dementia: A 28-year follow-up study

JAMA Psychiatry

Volumn 74, Issue 7, 2017, Pages 712-718

  Singh Manoux, Archana ^a,b   Dugravot, Aline ^a   Fournier, Agnes ^a   Abell, Jessica ^a,b   Ebmeier, Klaus ^c   Kivimäki, Mika ^b   Sabia, Severine ^a,b  

^a HÔPITAL PAUL BROUSSE   (France)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CHRONIC DEPRESSION; COHORT ANALYSIS; DEMENTIA; DEMOGRAPHY; EDUCATIONAL STATUS; ETHNIC DIFFERENCE; FEMALE; FOLLOW UP; GENERAL HEALTH QUESTIONNAIRE; HEALTH BEHAVIOR; HIGH SCHOOL; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MARRIAGE; OCCUPATION; RACE DIFFERENCE; RECURRENT DISEASE; RETROSPECTIVE STUDY; SEX DIFFERENCE; SOCIAL ASPECT; UNITED KINGDOM; AGED; COMORBIDITY; DEPRESSION; MIDDLE AGED; PRODROMAL SYMPTOM; RISK; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; COMORBIDITY; DEMENTIA; DEPRESSION; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MIDDLE AGED; PRODROMAL SYMPTOMS; RISK; UNITED KINGDOM;

EID: 85019645504     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2017.0660     Document Type: Article

References (36)

1. NelsonPT, BraakH, MarkesberyWR.Neuropathology and cognitive impairment in Alzheimer disease: acomplexbutcoherentrelationship. JNeuropatholExp Neurol. 2009;68(1):1-14
2. Jack CR Jr, Knopman DS, JagustWJ, et al. Tracking pathophysiologicalprocessesinAlzheimer'sdisease:an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013;12(2):207-216
3. Villemagne VL, Burnham S, Bourgeat P, et al; Australian Imaging Biomarkers and Lifestyle (AIBL) Research Group. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study. Lancet Neurol. 2013;12(4):357-367
4. Winblad B, Amouyel P, Andrieu S, et al. Defeating Alzheimer's disease and other dementias: a priority for European science and society. Lancet Neurol. 2016;15(5):455-532
5. Sperling RA, Jack CR Jr, Aisen PS. Testing the right target and right drug at the right stage. Sci Transl Med. 2011;3(111):111cm33
6. Ownby RL, Crocco E, Acevedo A, John V, Loewenstein D. Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry. 2006;63(5):530-538
7. Chen P, Ganguli M, Mulsant BH, DeKosky ST. The temporal relationship between depressive symptoms anddementia: acommunity-based prospective study. Arch Gen Psychiatry. 1999;56(3):261-266
8. Ganguli M, Du Y, Dodge HH, Ratcliff GG, Chang CC. Depressive symptoms and cognitive decline in late life: a prospective epidemiological study. Arch Gen Psychiatry. 2006;63(2):153-160
9. Geerlings MI, Schoevers RA, Beekman AT, et al. Depression and risk of cognitive decline and Alzheimer's disease: results of two prospective community-based studies in the Netherlands. Br J Psychiatry. 2000;176:568-575
10. Kaup AR, Byers AL, Falvey C, et al. Trajectories of depressive symptoms in older adults and risk of dementia. JAMA Psychiatry. 2016;73(5):525-531
11. Mirza SS, Wolters FJ, Swanson SA, et al. 10-year trajectories of depressive symptoms and risk of dementia: a population-based study. Lancet Psychiatry. 2016;3(7):628-635
12. Marmot MG, Smith GD, Stansfeld S, et al. Health inequalities among British civil servants: the Whitehall II Study. Lancet. 1991;337(8754):1387-1393
13. Goldberg DP. The Detection of Psychiatric Illness by Questionnaire. London, England: Oxford University Press; 1972
14. Stansfeld SA, Marmot MG. Social class and minor psychiatric disorder in British civil servants: a validated screening survey using the General Health Questionnaire. Psychol Med. 1992;22(3):739-749
15. Radloff L. The CES-D scale: a self report depression scale for research in the general population. Appl Psychol Meas. 1997;1:385-401
16. Head J, Stansfeld SA, Ebmeier KP, et al. Use of self-administered instruments to assess psychiatric disorders in older people: validity of the General Health Questionnaire, the Center for Epidemiologic Studies Depression Scale and the self-completion version of the revised Clinical Interview Schedule. Psychol Med. 2013;43(12):2649-2656
17. Singh-Manoux A, Kivimaki M, Glymour MM, et al. Timing of onset of cognitive decline: results from Whitehall II prospective cohort study. BMJ. 2012;344:d7622
18. Amieva H, Le Goff M, Millet X, et al. Prodromal Alzheimer's disease: successive emergence of the clinical symptoms. Ann Neurol. 2008;64(5):492-498
19. Starkstein SE, Jorge R, Mizrahi R, Robinson RG. The construct of minor and major depression in Alzheimer's disease. Am J Psychiatry. 2005;162(11): 2086-2093
20. Byers AL, Yaffe K. Depression and risk of developing dementia. Nat Rev Neurol. 2011;7(6):323-331
21. Babulal GM, Ghoshal N, Head D, et al. Mood changes in cognitively normal older adults are linked to Alzheimer disease biomarker levels. Am J Geriatr Psychiatry. 2016;24(11):1095-1104
22. Snowden MB, Atkins DC, Steinman LE, et al. Longitudinal association of dementia and depression. Am J Geriatr Psychiatry. 2015;23(9): 897-905
23. Wilson RS, Capuano AW, Boyle PA, et al. Clinical-pathologic study of depressive symptoms and cognitive decline in old age. Neurology. 2014; 83(8):702-709
24. Parker KJ, Schatzberg AF, Lyons DM. Neuroendocrine aspects of hypercortisolism in major depression. Horm Behav. 2003;43(1):60-66
25. Jacobson L, Sapolsky R. The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocr Rev. 1991;12(2):118-134
26. Geerlings MI, den Heijer T, Koudstaal PJ, Hofman A, Breteler MM. History of depression, depressive symptoms, and medial temporal lobe atrophy and the risk of Alzheimer disease. Neurology. 2008;70(15):1258-1264
27. Diniz BS, Butters MA, Albert SM, Dew MA, Reynolds CF III. Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies. Br J Psychiatry. 2013;202(5):329-335
28. Saczynski JS, Beiser A, Seshadri S, Auerbach S, Wolf PA, Au R. Depressive symptoms and risk of dementia: the Framingham Heart Study. Neurology. 2010;75(1):35-41
29. Dotson VM, Beydoun MA, Zonderman AB. Recurrent depressive symptoms and the incidence of dementia and mild cognitive impairment. Neurology. 2010;75(1):27-34
30. Chen R, Hu Z, Wei L, Qin X, McCracken C, Copeland JR. Severity of depression and risk for subsequent dementia: cohort studies in China and the UK. Br J Psychiatry. 2008;193(5):373-377
31. Wilson RS, Schneider JA, Bienias JL, Arnold SE, Evans DA, Bennett DA. Depressive symptoms, clinical AD, and cortical plaques and tangles in older persons. Neurology. 2003;61(8):1102-1107
32. Wilson RS, Barnes LL, Mendes de Leon CF, et al. Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology. 2002;59(3): 364-370
33. Li G, Wang LY, Shofer JB, et al. Temporal relationship between depression and dementia: findings from a large community-based 15-year follow-up study. Arch Gen Psychiatry. 2011;68(9): 970-977
34. Barnes DE, Yaffe K, Byers AL, McCormick M, Schaefer C, Whitmer RA. Midlife vs late-life depressive symptoms and risk of dementia: differential effects for Alzheimer disease and vascular dementia. Arch Gen Psychiatry. 2012;69 (5):493-498
35. Green RC, Cupples LA, Kurz A, et al. Depression as a risk factor for Alzheimer disease: the MIRAGE Study. Arch Neurol. 2003;60(5):753-759
36. Dal Forno G, Palermo MT, Donohue JE, Karagiozis H, Zonderman AB, Kawas CH. Depressive symptoms, sex, and risk for Alzheimer's disease. Ann Neurol. 2005;57(3):381-387